Revolution Medicines Inc. (RVMD)
NASDAQ: RVMD
· Real-Time Price · USD
36.30
0.28 (0.78%)
At close: Aug 15, 2025, 3:59 PM
36.32
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT
Revolution Medicines Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 261.59M | 261.59M | 261.59M | 742K | 742K | 4.57M | 11.58M | 26.17M | 29.52M | 34.82M | 35.38M | 29.51M | 27.25M | 26.84M | 29.39M | 28.68M | 40.24M | 41.57M |
Cost of Revenue | 134.51M | 143.57M | 261.59M | 133.65M | 135.8M | 124.8M | 9.31M | 9.05M | 76.36M | 76.92M | 76.68M | 76.14M | 53.16M | 96.76M | 135.33M | 170.27M | 158.67M | 145.65M |
Gross Profit | 127.08M | 118.02M | n/a | -132.91M | -135.06M | -120.23M | 2.27M | 17.12M | -46.84M | -42.1M | -41.3M | -46.63M | -25.9M | -69.92M | -105.94M | -141.59M | -118.43M | -104.08M |
Operating Income | -873.54M | -789.42M | -689.52M | -653.2M | -600.73M | -552.89M | -487.19M | -368.91M | -322.19M | -275.49M | -258.28M | -249.48M | -226.11M | -208.56M | -188.01M | -169.18M | -143.56M | -127.01M |
Interest Income | 91.47M | 88.04M | 86.88M | 84.64M | 75.17M | 64.18M | 47.48M | 33.58M | 25.54M | 15.91M | 9.15M | 4.31M | 1.63M | 998K | 929K | 944K | 1.07M | 1.56M |
Pretax Income | -778.44M | -698.26M | -600.85M | -566.72M | -522.73M | -487.8M | -439.89M | -335.33M | -296.65M | -259.58M | -249.13M | -245.17M | -224.49M | -207.56M | -187.09M | -168.26M | -142.54M | -125.51M |
Net Income | -777.69M | -697.51M | -600.09M | -567.06M | -519.21M | -484.27M | -426.77M | -321.75M | -286.64M | -248.7M | -247.54M | -243.71M | -223.32M | -207.26M | -187.09M | -168.62M | -142.9M | -125.82M |
Selling & General & Admin | 120.44M | 108.9M | 96.72M | 99.51M | 91.06M | 83.99M | 74.38M | 54.29M | 49.21M | 44.77M | 40.59M | 38.37M | 35.72M | 32.82M | 30.45M | 27.58M | 25.13M | 22.93M |
Research & Development | 748.81M | 679.95M | 592.23M | 551.57M | 507.56M | 470.6M | 421.53M | 340.79M | 302.51M | 265.53M | 253.07M | 240.63M | 217.65M | 202.58M | 186.95M | 170.27M | 158.67M | 145.65M |
Other Expenses | n/a | -12.78M | -130.8M | -130.8M | -130.8M | -118.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 869.83M | 776.65M | 558.73M | 520.28M | 467.82M | 436.57M | 495.91M | 395.08M | 351.72M | 310.3M | 293.66M | 278.99M | 253.37M | 235.4M | 217.4M | 197.86M | 183.8M | 168.58M |
Interest Expense | -899K | n/a | n/a | 9.29M | 9.29M | 9.29M | 9.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12K | 26K | 43K | 62K |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.24M | -1.24M | -1.24M | -1.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1B | 920.22M | 820.32M | 653.94M | 601.48M | 557.45M | 498.76M | 395.08M | 351.72M | 310.3M | 293.66M | 278.99M | 253.37M | 235.4M | 217.4M | 197.86M | 183.8M | 168.58M |
Income Tax Expense | 753K | 753K | 753K | 343K | 4.21M | 4.21M | -5.38M | -5.85M | -10.01M | -10.88M | -1.59M | -1.47M | -946K | 157K | 692K | 1.05M | 831K | 537K |
Shares Outstanding (Basic) | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.82M | 73.54M | 73.4M | 70.42M |
Shares Outstanding (Diluted) | 188.15M | 188.15M | 167.74M | 166.84M | 165.14M | 164.73M | 141.18M | 109.23M | 106.88M | 94.83M | 89.16M | 84.69M | 74.28M | 74.16M | 73.83M | 73.54M | 73.4M | 70.42M |
EPS (Basic) | -4.33 | -4.01 | -3.58 | -3.59 | -3.64 | -3.75 | -3.67 | -3.16 | -3.04 | -2.93 | -3.08 | -3.16 | -3.01 | -2.8 | -2.56 | -2.37 | -2.07 | -1.93 |
EPS (Diluted) | -4.33 | -4.01 | -3.58 | -3.59 | -3.64 | -3.75 | -3.67 | -3.16 | -3.04 | -2.93 | -3.08 | -3.16 | -3.01 | -2.8 | -2.56 | -2.37 | -2.07 | -1.93 |
EBITDA | -835.38M | -780.61M | -682.92M | -628.33M | -573.73M | -525.82M | -459.09M | -354.78M | -304.87M | -257.6M | -240.64M | -237.22M | -217.22M | -199.92M | -179.75M | -161.26M | -135.65M | -118.77M |
EBIT | -825.21M | -768.44M | -668.54M | -634.41M | -581.94M | -534.1M | -468.4M | -363.83M | -317.12M | -270.41M | -253.2M | -249.25M | -225.65M | -207.86M | -187.08M | -168.23M | -142.5M | -125.45M |
Depreciation & Amortization | 10.82M | 8.81M | 6.6M | 6.07M | 8.22M | 8.28M | 9.31M | 9.05M | 9.34M | 9.9M | 9.66M | 9.12M | 8.44M | 7.94M | 7.33M | 6.97M | 6.85M | 6.68M |